2009 H1N1 vax not linked to GBS

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1361, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Which H1N1 vax strategy is good value for money?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

2009 H1N1 Pandemic Influenza: Let's Get Involved!

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 4, 2009-12 ,pp. : 259-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics

By Widmer Nicolas

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 741-765

Adis International

Access to resources Recommend Favorite

What did the 2009 H1N1 pandemic teach us about influenza surveillance systems?

By Stoto Michael A

Future Virology, Vol. 8, Iss. 9, 2013-09 ,pp. : 829-832

Future Medicine

Access to resources Recommend Favorite

Flu vax not effective in α1-antitrypsin deficiency

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite